First Patient Dosed | DVAX Message Board Posts

Dynavax Technologies Corporation

  DVAX website

DVAX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1704 of 1764  at  6/19/2020 7:09:11 AM  by

warlord_2010


 In response to msg 1703 by  cre8profit
view thread

Re: First Patient Dosed

 
Jun 19, 2020 at 6:00 AM EDT
  • Preclinical results demonstrated the ability of CpG 1018-adjuvanted SCB-2019 to elicit neutralizing antibodies in multiple animal species
  • Clover expects to enroll 150 healthy adult and elderly participants in the Phase 1 study
  • Preliminary safety and immunogenicity results expected in August 2020
  • Dynavax is providing CpG 1018, the adjuvant contained in its U.S. FDA-approved adult hepatitis B vaccine, to enhance the immune response of Clover’s COVID-19 vaccine
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 62
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...